パルギリン (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "パルギリン" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

2,650^th place

3,384^th place

1,226^th place

1,988^th place

5^th place

19^th place

719^th place

3,311^th place

bmj.com

“Eutonyl and MAO inhibitors” (英語). Drug and Therapeutics Bulletin 1 (15): 59–60. (15 November 1963). doi:10.1136/dtb.1.15.59. ISSN 1755-5248. http://dtb.bmj.com/content/1/15/59. "Pargyline is promoted only for the treatment of hypertension, and not for depression."

“Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)”. J. Neural Transm. Suppl. 52: 39–48. (1998). doi:10.1007/978-3-7091-6499-0_5. PMID 9564606.
“Eutonyl and MAO inhibitors” (英語). Drug and Therapeutics Bulletin 1 (15): 59–60. (15 November 1963). doi:10.1136/dtb.1.15.59. ISSN 1755-5248. http://dtb.bmj.com/content/1/15/59. "Pargyline is promoted only for the treatment of hypertension, and not for depression."

Council on Drugs New Drugs and Developments in Therapeutics: Pargyline Hydrochloride (Eutonyl) JAMA. 1963;184(11):887. doi:10.1001/jama.1963.03700240079013.

“Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.”. Neuro Endocrinol Lett. 31 (5): 645–56. (2010). PMID 21200377.
“Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)”. J. Neural Transm. Suppl. 52: 39–48. (1998). doi:10.1007/978-3-7091-6499-0_5. PMID 9564606.

“Eutonyl and MAO inhibitors” (英語). Drug and Therapeutics Bulletin 1 (15): 59–60. (15 November 1963). doi:10.1136/dtb.1.15.59. ISSN 1755-5248. http://dtb.bmj.com/content/1/15/59. "Pargyline is promoted only for the treatment of hypertension, and not for depression."